Longitudinal Analysis of Neutralizing Potency against SARS-CoV-2 in the Recovered Patients after Treatment with or without Favipiravir

Saved in:
Bibliographic Details
Published inViruses Vol. 14; p. 670
Main Authors Kanako Shinada, Takashi Sato, Saya Moriyama, Yu Adachi, Masahiro Shinoda, Shinichiro Ota, Miwa Morikawa, Masamichi Mineshita, Takayuki Matsumura, Yoshimasa Takahashi, Masaharu Shinkai
Format Journal Article
LanguageJapanese
Published MDPI AG 24.03.2022
Subjects
Amides
Antibodies, Neutralizing
Antibodies, Viral
COVID-19
COVID-19 Drug Treatment
favipiravir
favipiravir; COVID-19; SARS-CoV-2; neutralizing antibody; neutralizing potency index; neutralization breadth index
Humans
Immunoglobulin G
Microbiology
neutralization breadth index
Neutralization Tests
neutralizing antibody
neutralizing potency index
Pyrazines
QR1-502
SARS-CoV-2
Spike Glycoprotein, Coronavirus
Online AccessGet full text

Cover

More Information
ISSN:1999-4915
DOI:10.3390/v14040670